Valo Health, Inc.
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of OPL-0301 Compared to Placebo in Adults With Post-Myocardial Infarction (MI) (NCT05327855) | Valo Health, Inc. | 2022-09-01 |
| Phase 2 Spectra Study to Evaluate the Safety and Efficacy of OPL-0401 in Patients With Diabetic Retinopathy (NCT05393284) | Valo Health, Inc. | 2022-08-16 |
Track Valo Health, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.